Led by Index Ventures with participation from GV (Google Ventures), this funding round underscores milestone growth, cross-country expansion, and new Chief Medical Officer "Allara was built for the ...

Virtual women’s health company Allara Health has raised $26 million in Series B funding, which it will use to further support women battling chronic hormonal conditions, the company announced on ...

Among reproductive-aged women, up to 13% suffer from polycystic ovary syndrome (PCOS) – and 70% go undiagnosed. It’s one of the main causes of infertility and is linked to several long-term health ...

Forbes contributors publish independent expert analyses and insights. Geri Stengel writes about the success factors of women entrepreneurs. Rachel Blank, CEO and Founder of Allara Driven by her ...

Chronic hormonal conditions such as polycystic ovarian syndrome (PCOS) and endometriosis are common in women, but also commonly go undiagnosed or inadequately treated. Allara, a New York–based ...

Chronic hormonal conditions are fairly common in women. For example, polycystic ovary syndrome (PCOS) affects up to 12% of U.S. women of reproductive age, and endometriosis affects about 11%. Despite ...

NEW YORK--(BUSINESS WIRE)--Allara, the first comprehensive care platform to support and empower the one in ten women with Polycystic Ovary Syndrome (PCOS), today announced the launch of their hormonal ...

Women’s telehealth continues to make waves in the startup world as investors look to capitalize on a historically shunted area of care delivery. Greenwich Village-based Allara Health is the latest ...

While it may take an average of three years for women with polycystic ovary syndrome to receive a definitive diagnosis, following multiple doctor visits, the testing company Allara hopes to reduce ...